CLINICAL TRIALS PROFILE FOR PHOTOFRIN
✉ Email this page to a colleague
All Clinical Trials for Photofrin
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002935 ↗ | Photodynamic Therapy in Treating Patients With Early Esophageal Cancer | Completed | Roswell Park Cancer Institute | Phase 2 | 1995-10-01 | RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective treatment for esophageal cancer. PURPOSE: Phase II trial to study the effectiveness of photodynamic therapy in treating patients with Barrett's esophagus who have in situ esophageal cancer. |
| NCT00002964 ↗ | Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer | Completed | Roswell Park Cancer Institute | Phase 2 | 1995-02-01 | RATIONALE: Drugs that make cancer cells more visible to light may help in the diagnosis of head and neck cancer. PURPOSE: Phase II trial to study the usefulness of porfimer sodium in diagnosing patients with head and neck cancer. |
| NCT00003788 ↗ | Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas | Unknown status | Colorado Health Foundation | Phase 3 | 1998-04-01 | RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. It is not yet known if the addition of photodynamic therapy to combined therapy with surgery, radiation therapy, and chemotherapy is more effective than combined therapy alone for supratentorial gliomas. PURPOSE: Randomized phase III trial to study the effectiveness of surgery, radiation therapy, and chemotherapy with or without photodynamic therapy in treating patients who have newly diagnosed or recurrent malignant supratentorial gliomas. |
| NCT00003923 ↗ | Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | Completed | National Cancer Institute (NCI) | Phase 2 | 1999-03-01 | RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be effective treatment for cancer of the bile duct, gallbladder, or pancreas. PURPOSE: Phase II trial to determine the effectiveness of photodynamic therapy in treating patients who have cancer of the bile duct, gallbladder, or pancreas. |
| NCT00003923 ↗ | Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | Completed | Memorial Sloan Kettering Cancer Center | Phase 2 | 1999-03-01 | RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be effective treatment for cancer of the bile duct, gallbladder, or pancreas. PURPOSE: Phase II trial to determine the effectiveness of photodynamic therapy in treating patients who have cancer of the bile duct, gallbladder, or pancreas. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Photofrin
Condition Name
Clinical Trial Locations for Photofrin
Trials by Country
Clinical Trial Progress for Photofrin
Clinical Trial Phase
Clinical Trial Sponsors for Photofrin
Sponsor Name
